BINOCRIT Trademark

Trademark Overview

On Friday, December 6, 2013, a trademark application was filed for BINOCRIT with the United States Patent and Trademark Office. The USPTO has given the BINOCRIT trademark a serial number of 86136716. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, March 27, 2017. This trademark is owned by Novartis AG. The BINOCRIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, the immune system and the cardiovascular system and for use in oncology; pharmaceutical preparations for the treatment of blood and blood forming organs
binocrit

General Information

Serial Number86136716
Word MarkBINOCRIT
Filing DateFriday, December 6, 2013
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, March 27, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, the immune system and the cardiovascular system and for use in oncology; pharmaceutical preparations for the treatment of blood and blood forming organs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, March 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, March 27, 2017ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Monday, March 27, 2017ABANDONMENT - AFTER PUBLICATION
Saturday, March 25, 2017TEAS EXPRESS ABANDONMENT RECEIVED
Friday, December 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2016EXTENSION 5 GRANTED
Tuesday, December 6, 2016EXTENSION 5 FILED
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Friday, June 10, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 9, 2016EXTENSION 4 GRANTED
Tuesday, June 7, 2016EXTENSION 4 FILED
Tuesday, June 7, 2016TEAS EXTENSION RECEIVED
Tuesday, December 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 12, 2015EXTENSION 3 GRANTED
Tuesday, December 8, 2015EXTENSION 3 FILED
Tuesday, December 8, 2015TEAS EXTENSION RECEIVED
Thursday, June 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2015EXTENSION 2 GRANTED
Sunday, May 31, 2015EXTENSION 2 FILED
Wednesday, June 24, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, May 31, 2015TEAS EXTENSION RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 8, 2014EXTENSION 1 GRANTED
Monday, December 8, 2014EXTENSION 1 FILED
Monday, December 8, 2014TEAS EXTENSION RECEIVED
Tuesday, June 10, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 15, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 15, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 7, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 28, 2014ASSIGNED TO EXAMINER
Wednesday, December 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 10, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

binocrit system blood treatment preparations pharmaceutical oncology forming organs cardiovascular nervous